Skip to main content
. Author manuscript; available in PMC: 2010 Jan 1.
Published in final edited form as: Nat Cell Biol. 2009 Jun 7;11(7):909–913. doi: 10.1038/ncb1901

Table1.

Semi-quantitative grading of filamentous tau pathology in ALZ17 mice injected with brain extract from mice transgenic for human P301S tau (n=5 for each time point).

Anterior (1.7 mm from injection level)
Time
6 months 12 months 15 months
Region

fimbria ++ +++ +++
thalamus + ++ ++
internal capsule + ++
caudate putamen + +
somatosensory cortex + +
hypothalamus +
amygdala +

Injection level
Time
6 months 12 months 15 months
Region

hippocampus *1 ++ +++ +++
optic tract ++ ++ +++
fimbria + ++ +++
medial lemniscus + ++ +++
zona incerta + ++ +++
thalamus + ++ ++
cerebral peduncle + ++ ++
visual cortex 2 + + ++
hypothalamus + + +
amygdala + +

Posterior (1.3 mm from injection level)
Time
6 months 12 months 15 months
Region

cerebral peduncle ++ +++ +++
hippocampus * + ++ +++
superior colliculus + ++ ++
substantia nigra + + +
entorhinal cortex + ++
deep mesencephalic nucleus + ++
pontine nuclei +

−: no Gallyas-Braak-positive structures; +: 0-20; ++: 20-40; +++: >40

*

CA1, CA2, CA3, dentate gyrus and subiculum

1

injection sites

2

injection sites